Report Detail

Pharma & Healthcare Global Liver Fibrosis Drug Sales Market Report 2019

  • RnM2791944
  • |
  • 22 January, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Liver Fibrosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Liver Fibrosis Drug market status and forecast, categorizes the global Liver Fibrosis Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Bird Rock Bio, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Genfit SA
Gilead Sciences, Inc.
GNI Group Ltd.
HEC Pharm Co., Ltd.
Dr. Falk Pharma GmbH
LG Life Science LTD.
Nitto Denko Corporation
Pfizer Inc.
Pharmaxis Limited
Promedior, Inc.
Dynavax Technologies Corporation
Evotec AG
FibroGen, Inc.

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Interferon
Maloti Lipid
Nucleoside
Other

Segment by Application
Research Center
Hospital
Clinic


Table of Contents

    Global Liver Fibrosis Drug Sales Market Report 2019

      1 Liver Fibrosis Drug Market Overview

      • 1.1 Liver Fibrosis DrugProduct Overview
      • 1.2 Liver Fibrosis Drug Segment by Type
        • 1.2.1 Global Liver Fibrosis Drug Sales Comparison by Types (2014-2025)
        • 1.2.2 Interferon
        • 1.2.3 Maloti Lipid
        • 1.2.4 Nucleoside
        • 1.2.5 Other
      • 1.3 Liver Fibrosis Drug Segment by Application
        • 1.3.1 Global Liver Fibrosis Drug Sales Comparison by Application (2014-2025)
        • 1.3.1 Research Center
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.4 Liver Fibrosis Drug Market by Region
        • 1.4.1 Global Liver Fibrosis Drug Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States Liver Fibrosis Drug Status and Prospect (2014-2025)
        • 1.4.3 Europe Liver Fibrosis Drug Status and Prospect (2014-2025)
        • 1.4.4 China Liver Fibrosis Drug Status and Prospect (2014-2025)
        • 1.4.5 Japan Liver Fibrosis Drug Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia Liver Fibrosis Drug Status and Prospect (2014-2025)
        • 1.4.7 India Liver Fibrosis Drug Status and Prospect (2014-2025)
      • 1.5 Global Liver Fibrosis Drug Sales and Revenue (2014-2025)
        • 1.5.1 Global Liver Fibrosis Drug Sales and Growth Rate (2014-2025)
        • 1.5.2 Global Liver Fibrosis Drug Revenue and Growth Rate (2014-2025)

      2 Liver Fibrosis Drug by Company, Region, Type and Application

      • 2.1 Global Liver Fibrosis Drug Market Competition by Companies
        • 2.1.1 Global Liver Fibrosis Drug Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global Liver Fibrosis Drug Revenue Market Share by Company (2014-2019)
      • 2.2 Global Liver Fibrosis Drug Sales and Revenue by Region
        • 2.2.1 Global Liver Fibrosis Drug Sales Market Share by Region (2014-2019)
        • 2.2.2 Global Liver Fibrosis Drug Revenue Market Share by Region (2014-2019)
      • 2.3 Global Liver Fibrosis Drug Sales and Revenue by Type
        • 2.3.1 Global Liver Fibrosis Drug Sales Market Share by Type (2014-2019)
        • 2.3.2 Global Liver Fibrosis Drug Revenue Market Share by Type (2014-2019)
      • 2.4 Global Liver Fibrosis Drug Sales by Application

      3 United States Liver Fibrosis Drug Sales, Revenue and Price

      • 3.1 United States Liver Fibrosis Drug Sales and Revenue (2014-2019)
        • 3.1.1 United States Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 3.1.2 United States Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 3.1.3 United States Liver Fibrosis Drug Price Trend (2014-2019)
      • 3.2 United States Liver Fibrosis Drug Sales Market Share by Company
      • 3.3 United States Liver Fibrosis Drug Sales Market Share by Type
      • 3.4 United States Liver Fibrosis Drug Sales Market Share by Application

      4 Europe Liver Fibrosis Drug Sales, Revenue and Price

      • 4.1 Europe Liver Fibrosis Drug Sales and Value (2014-2019)
        • 4.1.1 Europe Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 4.1.2 Europe Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe Liver Fibrosis Drug Price Trend (2014-2019)
      • 4.2 Europe Liver Fibrosis Drug Sales Market Share by Company
      • 4.3 Europe Liver Fibrosis Drug Sales Market Share by Type
      • 4.4 Europe Liver Fibrosis Drug Sales Market Share by Application

      5 China Liver Fibrosis Drug Sales, Revenue and Price

      • 5.1 China Liver Fibrosis Drug Sales and Revenue (2014-2019)
        • 5.1.1 China Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 5.1.2 China Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 5.1.3 China Liver Fibrosis Drug Price Trend (2014-2019)
      • 5.2 China Liver Fibrosis Drug Sales Market Share by Company
      • 5.3 China Liver Fibrosis Drug Sales Market Share by Type
      • 5.4 China Liver Fibrosis Drug Sales Market Share by Application

      6 Japan Liver Fibrosis Drug Sales, Revenue and Price

      • 6.1 Japan Liver Fibrosis Drug Sales and Value (2014-2019)
        • 6.1.1 Japan Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 6.1.2 Japan Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan Liver Fibrosis Drug Price Trend (2014-2019)
      • 6.2 Japan Liver Fibrosis Drug Sales Market Share by Company
      • 6.3 Japan Liver Fibrosis Drug Sales Market Share by Type
      • 6.4 Japan Liver Fibrosis Drug Sales Market Share by Application

      7 Southeast Asia Liver Fibrosis Drug Sales, Revenue and Price

      • 7.1 Southeast Asia Liver Fibrosis Drug Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia Liver Fibrosis Drug Price Trend (2014-2019)
      • 7.2 Southeast Asia Liver Fibrosis Drug Sales Market Share by Company
      • 7.3 Southeast Asia Liver Fibrosis Drug Sales Market Share by Type
      • 7.4 Southeast Asia Liver Fibrosis Drug Sales Market Share by Application

      8 India Liver Fibrosis Drug Sales, Revenue and Price

      • 8.1 India Liver Fibrosis Drug Sales and Value (2014-2019)
        • 8.1.1 India Liver Fibrosis Drug Sales Growth Rate (2014-2019)
        • 8.1.2 India Liver Fibrosis Drug Revenue Growth Rate (2014-2019)
        • 8.1.3 India Liver Fibrosis Drug Price Trend (2014-2019)
      • 8.2 India Liver Fibrosis Drug Sales Market Share by Company
      • 8.3 India Liver Fibrosis Drug Sales Market Share by Type
      • 8.4 India Liver Fibrosis Drug Sales Market Share by Application

      9 Company Profiles and Key Figures in Liver Fibrosis Drug Business

      • 9.1 Bird Rock Bio, Inc.
        • 9.1.1 Bird Rock Bio, Inc. Liver Fibrosis Drug Production Sites and Area Served
        • 9.1.2 Liver Fibrosis Drug Specification and Application
        • 9.1.3 Bird Rock Bio, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 Bristol-Myers Squibb Company
        • 9.2.1 Bristol-Myers Squibb Company Liver Fibrosis Drug Production Sites and Area Served
        • 9.2.2 Liver Fibrosis Drug Specification and Application
        • 9.2.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 Celgene Corporation
        • 9.3.1 Celgene Corporation Liver Fibrosis Drug Production Sites and Area Served
        • 9.3.2 Liver Fibrosis Drug Specification and Application
        • 9.3.3 Celgene Corporation Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Dicerna Pharmaceuticals, Inc.
        • 9.4.1 Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Production Sites and Area Served
        • 9.4.2 Liver Fibrosis Drug Specification and Application
        • 9.4.3 Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 Digna Biotech, S.L.
        • 9.5.1 Digna Biotech, S.L. Liver Fibrosis Drug Production Sites and Area Served
        • 9.5.2 Liver Fibrosis Drug Specification and Application
        • 9.5.3 Digna Biotech, S.L. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Genfit SA
        • 9.6.1 Genfit SA Liver Fibrosis Drug Production Sites and Area Served
        • 9.6.2 Liver Fibrosis Drug Specification and Application
        • 9.6.3 Genfit SA Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Gilead Sciences, Inc.
        • 9.7.1 Gilead Sciences, Inc. Production Sites and Area Served
        • 9.7.2 Liver Fibrosis Drug Specification and Application
        • 9.7.3 Gilead Sciences, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 GNI Group Ltd.
        • 9.8.1 GNI Group Ltd. Liver Fibrosis Drug Production Sites and Area Served
        • 9.8.2 Liver Fibrosis Drug Specification and Application
        • 9.8.3 GNI Group Ltd. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 HEC Pharm Co., Ltd.
        • 9.9.1 HEC Pharm Co., Ltd. Liver Fibrosis Drug Production Sites and Area Served
        • 9.9.2 Liver Fibrosis Drug Specification and Application
        • 9.9.3 HEC Pharm Co., Ltd. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Dr. Falk Pharma GmbH
        • 9.10.1 Dr. Falk Pharma GmbH Liver Fibrosis Drug Production Sites and Area Served
        • 9.10.2 Liver Fibrosis Drug Specification and Application
        • 9.10.3 Dr. Falk Pharma GmbH Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 LG Life Science LTD.
      • 9.12 Nitto Denko Corporation
      • 9.13 Pfizer Inc.
      • 9.14 Pharmaxis Limited
      • 9.15 Promedior, Inc.
      • 9.16 Dynavax Technologies Corporation
      • 9.17 Evotec AG
      • 9.18 FibroGen, Inc.

      10 Liver Fibrosis Drug Maufacturing Cost Analysis

      • 10.1 Liver Fibrosis Drug Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of Liver Fibrosis Drug
      • 10.4 Liver Fibrosis Drug Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 Liver Fibrosis Drug Distributors List
      • 11.3 Liver Fibrosis Drug Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 Liver Fibrosis Drug Market Forecast

      • 13.1 Global Liver Fibrosis Drug Sales, Revenue and Price Forecast
        • 13.1.1 Global Liver Fibrosis Drug Sales Growth Forecast (2019-2025)
        • 13.1.2 Global Liver Fibrosis Drug Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global Liver Fibrosis Drug Price Trend Forecast (2019-2025)
      • 13.2 Global Liver Fibrosis Drug Forecast by Region
        • 13.2.1 Global Liver Fibrosis Drug Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global Liver Fibrosis Drug Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India Liver Fibrosis Drug Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global Liver Fibrosis Drug Forecast by Type
        • 13.3.1 Global Liver Fibrosis Drug Sales Forecast by Type (2019-2025)
        • 13.3.2 Global Liver Fibrosis Drug Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global Liver Fibrosis Drug Price Forecast by Type (2019-2025)
      • 13.4 Global Liver Fibrosis Drug Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        Summary:
        Get latest Market Research Reports on Liver Fibrosis Drug. Industry analysis & Market Report on Liver Fibrosis Drug is a syndicated market report, published as Global Liver Fibrosis Drug Sales Market Report 2019. It is complete Research Study and Industry Analysis of Liver Fibrosis Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,000.00
        $6,000.00
        $8,000.00
        3,084.00
        4,626.00
        6,168.00
        3,704.00
        5,556.00
        7,408.00
        612,960.00
        919,440.00
        1,225,920.00
        337,320.00
        505,980.00
        674,640.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report